Suppression of regulatory factor X 7 alleviates airway remodeling and inflammation in childhood asthma
Cytojournal · 12.02.2025 · 22 · 15
DOI: 10.25259/cytojournal_138_2024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cytojournal, online erschienen am 12.02.2025. Verfasst von Yahui Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Ji'an Hospital, Shanghai East Hospital, Ji'an, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
Childhood asthma is a chronic heterogeneous syndrome composed of distinct disease entities or phenotypes. This study was conducted to characterize regulatory factor X 7 (RFX7) in childhood asthma. Material and Methods: Two available transcriptome datasets (GSE65204 and GSE27011) were used to analyze regulatory factor X (RFX) family members in childhood asthma. Random forest, logistic regression, and linear support vector machine (SVM) analyses were performed to construct an RFX-based classification model. Airway smooth muscle cells (ASMCs) were induced through platelet-derived growth factor-BB (PDGF-BB) for an asthma in vitro model. RFX7 expression was measured through immunoblotting. RFX7 was knocked out by transfection of RFX7 small-interfering RNAs, and then airway remodeling and inflammation were assayed.
Results
Among RFX family members, RFX3, RFX7, and RFX-associated protein displayed differential expression in childhood asthma versus healthy controls. Thus, SVM, logistic regression, and random forest-based machine learning models were built. The random forest model presented the best diagnostic efficacy (area under the curve [AUC] = 1 and 0.67 in discovery and verification sets). RFX7 was found to be effective in diagnosing childhood asthma (AUC = 0.724 and 0.775 in discovery and verification sets). In addition, RFX7 was overexpressed in PDGF-BB-stimulated ASMCs ( ✶ ✶ P < 0.01). Silencing RFX7 remarkably attenuated the proliferative and migrative capacities of ASMCs with PDGF-BB stimulation ( ✶ ✶ P < 0.01). In addition, RFX7 was positively related to neutrophil infiltration in childhood asthma, and its knockdown downregulated the levels of pro-inflammatory cytokines in PDGF-BB-stimulated ASMCs ( ✶ ✶ P < 0.01).
Conclusion
The findings of this study indicate that RFX7 is a novel molecule that is correlated with airway remodeling and inflammation in childhood asthma, providing insights into the mechanism underlying this disease and its potential clinical importance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Ji'an Hospital, Shanghai East Hospital, Ji'an, China.
- Department of Pediatrics, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
ORCID-Profile: Fang Liu
Zitieren
APA
Wu, Y., Dai, T., Qin, J., Guo, J., Fan, J., Mei, J., Li, X., & Liu, F. (2025). Suppression of regulatory factor X 7 alleviates airway remodeling and inflammation in childhood asthma. Cytojournal, 22, 15. https://doi.org/10.25259/cytojournal_138_2024
Vancouver
Wu Y, Dai T, Qin J, Guo J, Fan J, Mei J, et al. Suppression of regulatory factor X 7 alleviates airway remodeling and inflammation in childhood asthma. Cytojournal. 2025;22:15. doi:10.25259/cytojournal_138_2024
BibTeX
@article{Wu2025,
author = {Wu, Yahui and Dai, Tiansheng and Qin, Jingwen and Guo, Jian and Fan, Jitao and Mei, Jun and Li, Xiaoli and Liu, Fang},
title = {Suppression of regulatory factor X 7 alleviates airway remodeling and inflammation in childhood asthma},
journal = {Cytojournal},
year = {2025},
volume = {22},
pages = {15},
doi = {10.25259/cytojournal_138_2024}
}
EUVIMED